| Literature DB >> 29194531 |
Horace Roman1,2, Michael Bubenheim3, Emmanuel Huet4, Valérie Bridoux4, Chrysoula Zacharopoulou5, Emile Daraï5,6,7, Pierre Collinet8, Jean-Jacques Tuech4.
Abstract
STUDY QUESTION: Is there a difference in functional outcome between conservative versus radical rectal surgery in patients with large deep endometriosis infiltrating the rectum 2 years postoperatively? SUMMARY ANSWER: No evidence was found that functional outcomes differed when conservative surgery was compared to radical rectal surgery for deeply invasive endometriosis involving the bowel. WHAT IS KNOWN ALREADY: Adopting a conservative approach to the surgical management of deep endometriosis infiltrating the rectum, by employing shaving or disc excision, appears to yield improved digestive functional outcomes. However, previous comparative studies were not randomized, introducing a possible bias regarding the presumed superiority of conservative techniques due to the inclusion of patients with more severe deep endometriosis who underwent colorectal resection. STUDY DESIGN SIZE, DURATION: From March 2011 to August 2013, we performed a 2-arm randomized trial, enroling 60 patients with deep endometriosis infiltrating the rectum up to 15 cm from the anus, measuring more than 20 mm in length, involving at least the muscular layer in depth and up to 50% of rectal circumference. No women were lost to follow-up. PARTICIPANTS/MATERIALS, SETTING,Entities:
Keywords: bladder dysfunction; colorectal resection; conservative surgery; deep infiltrating endometriosis; digestive symptoms; disc excision; shaving
Mesh:
Year: 2018 PMID: 29194531 PMCID: PMC5850309 DOI: 10.1093/humrep/dex336
Source DB: PubMed Journal: Hum Reprod ISSN: 0268-1161 Impact factor: 6.918
Figure 1Flow diagram (CONSORT 2010).
Patients’ baseline characteristics.
| Parameter | Conservative surgery ( | Segmental resection ( |
|---|---|---|
| Age (years) | 31 (27–36) | 28 (27–36) |
| Dysmenorrhoea | ||
| VAS of dysmenorrhoea | 8 (8–10) | 9 (8–10) |
| Sexual intercourse during past year | 24 (88.9%) | 31 (93.9%) |
| Dyspareunia | ||
| VAS of dyspareunia | 5 (4–7) | 5 (3–7) |
| Chronic intermenstrual pelvic pain | ||
| VAS of intermenstrual chronic pelvic pain | 6 (5–7) | 5 (3–8) |
| Biberoglou & Behrman score | 4 (3–5) | 5 (4–6) |
| Digestive symptoms | ||
| ≤1 stool/5 days | 8 (29.7%) | 14 (42.4%) |
| Defecation pain | 21 (77.8%) | 24 (72.7%) |
| ≥3 stools/day | 11 (40.7%) | 12 (36.4%) |
| Involuntary gas or stool loss | 6 (22.2%) | 10 (30.3%) |
| GIQLI score | 89 (82–105) | 92 (86–104) |
| KESS score | 13 (9–18) | 10 (7–19) |
| Wexner score | 0 (0–3) | 1 (0–4) |
| How long were you able to defer defecation? | ||
| <5 min | 6 (22.2%) | 3 (9.1%) |
| 5–10 min | 6 (22.2%) | 10 (30.3%) |
| 10–15 min | 4 (14.8%) | 1 (3%) |
| >15 min | 11 (40.7%) | 19 (57.6%) |
| Urinary symptoms | ||
| USP score | 0 (0–3) | 0 (0–1) |
| Catamenial urinary pain or haematuria | 8 (29.7%) | 7 (21.2%) |
| Short Form 36 Health Survey score | 54 (44–67) | 48 (40–61) |
| Localization of deep nodules of digestive tract | ||
| - Rectal nodules | ||
| 1 nodule | 26 (96.3%) | 32 (97%) |
| 2 nodules | 1 (3.7%) | 1 (3%) |
| - Sigmoid colon nodules | ||
| 1 nodule | 10 (37%) | 15 (45.5%) |
| 2 nodules | 1 (3.7%) | 1 (3%) |
| 3 nodules | 1 (3.7%) | 0 |
| - Left, transverse, right colon and caecum nodules | 2 (7.4%) | 2 (6%) |
| - Small bowel nodules | 2 (7.4%) | 1 (3%) |
| Diameter of largest rectal nodule (mm) | 30 (26–40) | 30 (25–39) |
| Deepest infiltration of the rectum | ||
| - Muscular layer | 17 (63%) | 24 (72.7%) |
| - Submucosa | 9 (33.3%) | 8 (24.2%) |
| - Mucosa | 1 (3.7%) | 1 (3%) |
| Height of the lowest nodule (mm from anal verge) | 80 (60–100) | 90 (70–110) |
Data are n(%) or median (Q1–Q3). VAS, visual analog scale; GIQLI, gastrointestinal quality of life index; KESS, Knowles–Eccersley–Scott-Symptom; USP, urinary symptom profile.
Figure 2Preoperative MRI assessment in patients managed by shaving (a), disc excision (b) and segmental resection (c).
Intraoperative findings and surgical procedures.
| Parameter | Conservative surgery ( | Segmental resection ( |
|---|---|---|
| Operative route | ||
| Laparoscopic | 24 (88.9%) | 32 (97%) |
| Laparoscopic converted to open surgery | 3 (11.1%) | 1 (3%) |
| Operative time (min) | 280 (190–360) | 270 (230–300) |
| Procedure performed on the rectum | ||
| Shaving | 10 (37%) | 0 |
| Full thickness disc excision | 15 (55.6%) | 0 |
| Colorectal segmental resection | 2 (7.4%) | 33 (100%) |
| Full thickness disc excision | 15 (55.6%) | 0 |
| Diameter of the specimen (mm) | 40 (40–50) | – |
| Height of rectal suture (mm) | 70 (50–90) | – |
| Colorectal segmental resection | 2 | 33 |
| Length of colorectal specimen (mm) | 100 (100–150) | 80 (50–150) |
| Length of rectal segment removed (mm) | 60 (60–60) | 50 (40–70) |
| Length of sigmoid colon segment removed (mm) | 40 (40–90) | 20 (0–60) |
| Height of colorectal anastomosis (mm) | 90 (90–90) | 80 (60–100) |
| Temporary stoma | 16 (59.3%) | 21 (63.6%) |
| Ileostoma | 0 | 9 (27.3%) |
| Colostoma | 16 (59.3%) | 12 (36.4%) |
| AFSr score | 55 (19–98) | 54 (28–91) |
| Management of ovarian endometrioma | 8 (29.6%) | 13 (39.4%) |
| Right ovary | 7 (25.9%) | 7 (21.2%) |
| Left ovary | 4 (14.8%) | 12 (36.4%) |
| Resection of bladder nodule | 3 (11.1%) | 1 (3%) |
| Management of ureteral endometriosis | 4 (14.8%) | 4 (12.1%) |
| Advanced ureterolysis | 3 (11.1%) | 4 (12.1%) |
| Resection of the ureter and reimplantation into the bladder | 1 (3.7%) | 0 |
| Segmental resection of sigmoid colon (separated from rectal procedure) | 3 (11.1%) | 3 (9.1%) |
| Selective resection of left, transverse, right colon or caecum | 3 (11.1%) | 2 (6.1%) |
| Appendectomy | 4 (14.8%) | 2 (6.1%) |
| Resection of posterior vagina | 24 (88.9%) | 20 (60.6%) |
| Hysterectomy | 7 (25.9%) | 5 (15.2%) |
| Adnexectomy | 5 (18.5%) | 4 (12.1%) |
| Right | 4 (14.8%) | 2 (6.1%) |
| Left | 4 (14.8%) | 3 (9.1%) |
| Omentoplasty | 18 (66.7%) | 25 (75.8%) |
| Intraoperative blood loss (mL) | 200 (200–300) | 200 (150–300) |
| Blood transfusion | 0 | 0 |
Data are n(%) or median (Q1–Q3). AFSr, American Fertility Society Score.
Postoperative complications.
| Complications | Conservative surgery ( | Segmental resection ( | |
|---|---|---|---|
| Clavien Dindo 1 | 9 (33%) | 7 (21.2%) | 0.38 |
| Clavien Dindo 2 | 12 (44%) | 9 (27.3%) | 0.19 |
| Bladder atony requiring self-catheterization after Day 7 | 6a (22%) | 3 (9.1%) | 0.28 |
| Clavien Dindo 3 | 6a (22%) | 10 (3.3%) | 0.57 |
| Rectovaginal fistula | 2a (7.4%) | 0 | 0.20 |
| Stenosis of rectal lumen requiring additional procedure | 0 | 5 (15.2%) | 0.05 |
| Pelvic abscess | 0 | 1 (3%) | 1 |
| Complications related to stoma repair (leakage, abdominal haemorrhage, hernia) | 2 (7.4%) | 1 (3%) | 0.58 |
| Rectorrhage requiring endoscopy in emergency | 0 | 1 (3%) | 1 |
Data are n(%) or median (Q1–Q3).
aOne patient was managed by colorectal resection (conversion).
Clinical assessment 24 months after surgery.
| Parameter | Conservative surgery | Segmental resection | OR | 95% CI | |
|---|---|---|---|---|---|
| Arm A ( | Arm B ( | ||||
| Days of follow-up | 729 (726–743) | 727 (722–736) | 0.58 | 0.23–1.44 | 0.25 |
| Assessment of digestive and urinary function | |||||
| Patients presenting primary outcome | 13 (48%) | 13 (39%) | 0.70 | 0.22–2.21 | 0.60 |
| GIQLI score | 111 (97–135) | 121 (99–128) | 0.80 | 0.33–1.99 | 0.64 |
| KESS score | 10 (5–15) | 9 (5–17) | 1.10 | 0.46–2.67 | 0.83 |
| Wexner score | 0 (0–1) | 0 (0–2) | 2.10 | 0.71–6.22 | 0.23 |
| How long were you able to defer defecation? | 0.67 | 0.26–1.76 | 0.42 | ||
| <5 min | 5 (19%) | 6 (18%) | |||
| 5–10 min | 4 (15%) | 8 (24%) | |||
| 10–15 min | 3 (11%) | 4 (12%) | |||
| >15 min | 15 (56%) | 15 (45%) | |||
| USP of dysuria | 0 (0–1) | 0 (0–0) | 0.26 | 0.06–1.14 | 0.65 |
| Short Form 36 Health Survey score | 86 (64–92) | 82 (62–87) | 0.70 | 0.28–1.72 | 0.44 |
| Physical functioning | 95 (90–100) | 100 (80–100) | 0.94 | 0.37–2.41 | 0.91 |
| Physical role functioning | 100 (50–100) | 100 (100–100) | 1.56 | 0.51–4.73 | 0.44 |
| Bodily pain | 84 (62–100) | 74 (61–100) | 0.56 | 0.22–1.39 | 0.21 |
| General health perceptions | 72 (50–90) | 67 (52–82) | 0.84 | 0.34–2.06 | 0.71 |
| Vitality | 60 (40–75) | 55 (40–70) | 0.84 | 0.34–2.06 | 0.71 |
| Social functioning | 100 (75–100) | 88 (63–100) | 1.28 | 0.5–3.28 | 0.37 |
| Emotional role functioning | 100 (67–100) | 100 (67–100) | 2.07 | 0.7–6.15 | 0.82 |
| Mental health | 76 (52–88) | 68 (56–80) | 0.62 | 0.25–1.53 | 0.31 |
| Assessment of postoperative pelvic pain | |||||
| Patients with menstruation during preceding 6 months | 9 (33%) | 15 (45%) | 1.41 | 0.38–5.22 | 0.77 |
| Among whom, patients with dysmenorrhoea | 4/9 (44%) | 8/15 (53%) | 1.43 | 0.2–10.4 | 1.00 |
| VAS of dysmenorrhoea | 3 (2–4) | 4 (3–6) | 1.24 | 0.14–11.34 | 0.86 |
| Months until first recurrence of dysmenorrhoea | 12 (5–18) | 10 (4–18) | 1.00 | 0.1–10.2 | 1.00 |
| Patients having sexual intercourse after surgery during preceding 6 months | 24 (89%) | 32 (97%) | 4.00 | 0.29–216.4 | 0.32 |
| Among whom, patients with dyspareunia | 8/24 (33%) | 9/32 (28%) | 0.78 | 0.21–2.9 | 0.77 |
| VAS of dyspareunia | 4 (3–6) | 4 (3–7) | 1.00 | 0.19–5.3 | 1.00 |
| Patients with intermenstrual pelvic pain during preceding 6 months | 6 (22%) | 10 (3%) | 1.50 | 0.41–6 | 0.57 |
| VAS of intermenstrual pelvic pain | 4 (3–5) | 4 (3–6) | 1.23 | 0.21–7.38 | 0.83 |
Data are n(%) or median (Q1–Q3).
Figure 3Cumulative distribution functions of different scores: Short Form 36 Health Survey (SF36; Top-left corner), Gastrointestinal Quality of Life Index (GIQLI; Top-right corner), Knowles–Eccersley–Scott-symptom questionnaire (KESS; bottom-left corner) and the Wexner scale (bottom-right corner). Black lines correspond to the conservative surgery group, red lines correspond to the segmental resection group.